Google Funded Start-Up Calico Partners With AbbVie To Develop New Drugs

Business / Science / Tech

Google is one of the most interesting technology companies on the planet.  They started out as a simple search engine but have since had their hands into robotics and self-driving cars. Now the Google funded start-up, Calico, is partnering with AbbVie to develop new drugs that could battle diseases that strike the elderly. The partnership is looking to spend $1.5 billion dollars to research and market drugs that would treat cancer and Alzheimers.

The pact, which calls for the establishment of a new research and development center in the San Francisco Bay area, is an outgrowth of the research and development company Google launched a year ago whose mission is to leverage advanced technology to increase understanding of the biology that controls life span.

Its collaboration with AbbVie, a global pharmaceutical company that specializes in bringing drugs from late-stage development to market, lends it with instant credibility and institutional expertise. AbbVie, whose multi-use drug Humira is the biggest-selling drug in the world, also has treatments for cancer, thyroid disease and heart disease.

The Apple and Google war on the mobile front seems to be what takes the headlines these days so it’s nice to break up the fray a bit with Google news of a different sort. Calico is headed up by Arthur Levinson who is the chairman of Genentech and Apple Inc. which is interesting given the competiton between Google and Apple.

“Our relationship with AbbVie is a pivotal event for Calico, whose mission is to develop life-enhancing therapies for people with age-related diseases,” Levinson said in a statement. “It will greatly accelerate our efforts to understand the science of aging, advance our clinical work, and help bring important new therapies to patients everywhere.”

Calico and AbbVie will be splitting the costs of this venture straight down the middle and share equally in the profits. It will be interesting to see where both companies take this research. It’s a good thing to see investment into research to battle disease so here’s hoping some awesome discoveries are made.

  Source: Chicago Tribune

Featured image courtesy

To Top